Promomed

Main

News

Main
All news
Mass media
Reports
Press service

All sources

Corporate

For investors

Production

Medicinal preparations

Industry development

Education

All years

2025

2024

2023

2022

2021

2020

May

30May

PROMOMED Serves as General Partner of the 2025 National Diabetology Congress

Corporate
Medicinal preparations

May

30May

Innovative Alliance: PROMOMED and Startup Scientific Compliance Enter into Collaboration on Novel Drug Research

Corporate
For investors
Medicinal preparations

May

6May

One-Third Less: Tirzetta®—Russia’s First Tirzepatide—Now More Affordable for Patients

Corporate
Production
Medicinal preparations

April

21April

Prescription by Subscription: PROMOMED Launches Russia’s First Patient-Focused Pharma Subscription Program

For investors
Production
Medicinal preparations
Industry development

April

18April

PROMOMED: Building the Future of Russian Pharma Together with Young Experts at GxP-Fest 2025

Corporate
Industry development
Education

April

11April

Russia’s Minister of Science and Higher Education Highlights PROMOMED’s Contribution to Youth Science and Talent Development

Corporate
Production
Industry development
Education

April

10April

PROMOMED Wins “Deal of the Year” at Platinum Ounce Awards

Corporate
For investors
Industry development

April

1April

PROMOMED 2025: Celebrating 20 Years of Innovation, Strategic Growth, and Market Leadership

Corporate
For investors
Production
Industry development

March

20March

PROMOMED Ranked Among Russia’s Top Pharmaceutical Companies by Forbes

Corporate
For investors
Production
Industry development

March

17March

Priority 2030": Staying the Course Toward Technological Leadership

Corporate
For investors
Production
Industry development
Education

For investors

Information disclosure

Contacts

Menu

For investors

News

May

PROMOMED Serves as General Partner of the 2025 National Diabetology Congress

May

Innovative Alliance: PROMOMED and Startup Scientific Compliance Enter into Collaboration on Novel Drug Research

May

One-Third Less: Tirzetta®—Russia’s First Tirzepatide—Now More Affordable for Patients

April

Prescription by Subscription: PROMOMED Launches Russia’s First Patient-Focused Pharma Subscription Program

April

PROMOMED: Building the Future of Russian Pharma Together with Young Experts at GxP-Fest 2025

April

Russia’s Minister of Science and Higher Education Highlights PROMOMED’s Contribution to Youth Science and Talent Development

April

PROMOMED Wins “Deal of the Year” at Platinum Ounce Awards

April

PROMOMED 2025: Celebrating 20 Years of Innovation, Strategic Growth, and Market Leadership

March

PROMOMED Ranked Among Russia’s Top Pharmaceutical Companies by Forbes

March

Priority 2030": Staying the Course Toward Technological Leadership

For investors

Products

Pharmacovigilance